Gensight will attend the American Academy of Neurology (AAN) Annual Meeting scheduled for April 25–May 1, 2020, in Toronto, Canada.
A scientific abstract has been accepted for an oral presentation.
Abstract Title: rAAV2/2-ND4 for the Treatment of Leber Hereditary Optic Neuropathy (LHON): Final Results from the RESCUE and REVERSE Phase III Clinical Trials and Experimental Data in Nonhuman Primates to Support a Bilateral Effect
- Presenter: Mark L. Moster, MD, Neuro-Ophthalmology, Wills Eye Hospital and Professor of Neurology and Ophthalmology at Thomas Jefferson University, Philadelphia, PA, USA ; Principal Investigator in the REVERSE, RESCUE, and REFLECT trials
- Session Name: S32 – Neuro-ophthalmology/Neuro-otology
- Topic: Neuro-ophthalmology/Neuro-otology
- Program Number: 005
Read more: https://bit.ly/2xjiWo8